Primary Aldosteronism in a Patient with Autosomal Dominant Polycystic Kidney Disease Associated with Polycystic Liver Disease

1. Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrology Dialysis Transplantation. 2016 Jun 20;32(8):1356-63. DOI: 10.1093/ndt/gfw240.10.1093/ndt/gfw240Search in Google Scholar

2. Patel V, Chowdhury R, Igarashi P. Advances in the pathogenesis and treatment of polycystic kidney disease. Current opinion in nephrology and hypertension. 2009;18(2):99-106. DOI: 10.1097/MNH.0b013e3283262ab0.10.1097/MNH.0b013e3283262ab0Open DOISearch in Google Scholar

3. Trujillano D, Bullich G, Ossowski S, Ballarín J, Torra R, Estivill X, Ars E. Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next‐generation sequencing. Molecular genetics & genomic medicine. 2014 Sep 1;2(5):412-21. DOI: 10.1002/mgg3.8210.1002/mgg3.82Open DOISearch in Google Scholar

4. Akoh JA. Current management of autosomal dominant polycystic kidney disease. World journal of nephrology. 2015;4(4):468-79. DOI: 10.5527/wjn.v4.i4.468.10.5527/wjn.v4.i4.468Open DOISearch in Google Scholar

5. Ka EF, Seck SM, Niang A, Cisse MM, Diouf B. Patterns of autosomal dominant polycystic kidney diseases in black Africans. Saudi Journal of Kidney Diseases and Transplantation. 2010 Jan 1;21(1):81.Search in Google Scholar

6. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. The Journal of Clinical Endocrinology & Metabolism. 2004 Mar 1;89(3):1045-50. DOI: 10.1210/jc.2003-03133710.1210/jc.2003-031337Open DOISearch in Google Scholar

7. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. The Lancet. 2008 Jun 7;371(9628):1921-6. DOI: 10.1016/S0140-6736(08)60834-X.10.1016/S0140-6736(08)60834-XOpen DOISearch in Google Scholar

8. Fagugli RM, Taglioni C. Changes in the perceived epidemiology of primary hyperaldosteronism. International journal of hypertension. 2011 Aug 4;2011.. DOI: 10.4061/2011/16280410.4061/2011/162804315150721837271Search in Google Scholar

9. Trifanescu R, Carsote M, Caragheorgheopol A, Hortopan D, Dumitrascu A, Dobrescu M, Poiana C. Screening for secondary endocrine hypertension in young patients. Maedica. 2013 Jun;8(2):108-15.Search in Google Scholar

10. Chow KM, Ma RC, Szeto CC, Li PK. Polycystic kidney disease presenting with hypertension and hypokalemia. American Journal of Kidney Diseases. 2012 Feb 1;59(2):270-2. doi:10.1053/j.ajkd.2011.08.02010.1053/j.ajkd.2011.08.02021962616Search in Google Scholar

11. Bobrie G, Sirieix ME, Day M, Landais P, Lacombe M, Grünfeld JP. Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrology Dialysis Transplantation. 1992 Jan 1;7(7):647-50. DOI: 10.1093/ndt/7.7.647.10.1093/ndt/7.7.6471323077Open DOISearch in Google Scholar

12. Gejyo F, Ishida K, Arakawa M. Autosomal dominant polycystic kidney disease complicated by primary aldosteronism. American journal of nephrology. 1994;14(3):236-8. DOI: 10.1159/00016872510.1159/0001687257977490Search in Google Scholar

13. Rajasoorya, Chee TS, Ng BK. Hypertension in disguise--a trap for the unwary. European journal of endocrinology. 1995;133(1):93-6. DOI: 10.1530/eje.0.133009310.1530/eje.0.1330093Open DOISearch in Google Scholar

14. Liou HH, Tsai SC, Chen WJ, Huang TP, Huang WJ, Chen KK. The association of aldosterone-producing adrenal adenoma in a patient with autosomal dominant polycystic kidney disease. American journal of kidney diseases. 1994 May 1;23(5):739-42.10.1016/S0272-6386(12)70287-1Search in Google Scholar

15. Hoorn EJ, Hesselink DA, Kho MM, Roodnat JI, Weimar W, Van Saase JL, Van Den Meiracker AH, Zietse R. A case of primary aldosteronism revealed after renal transplantation. Nature Reviews Nephrology. 2011 Jan;7(1):55. DOI: 10.1038/nrneph.2010.15810.1038/nrneph.2010.15821102541Open DOISearch in Google Scholar

16. Kao C-C, Wu V-C, Kuo C-C, Lin Y-H, Hu Y-H, Tsai Y-C, et al. Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases. Journal of the Renin-Angiotensin-Aldosterone System. 2013;14(2):167-73. DOI: 10.1177/147032031245276710.1177/147032031245276722791703Open DOISearch in Google Scholar

17. Torres VE, Young Jr WF. Offord KP. Hattery RR: Association of hypokalemia, aldosteronism, and renal cysts. N EngI J Med. 1990;322:345-51. doi:10.1056/NEJM19900208322060110.1056/NEJM1990020832206012405267Open DOISearch in Google Scholar

18. Torres VE, Donovan KA, Scicli G, Holley KE, Thibodeau SN, Carretero OA, Inagami T, McAteer JA, Johnson CM. Synthesis of renin by tubulocystic epithelium in autosomaldominant polycystic kidney disease. Kidney international. 1992 Aug 1;42(2):364-73.10.1038/ki.1992.2971405319Search in Google Scholar

19. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin–angiotensin–aldosterone system and autosomal dominant polycystic kidney disease. New England Journal of Medicine. 1990 Oct 18;323(16):1091-6. DOI: 10.1056/NEJM19901018323160210.1056/NEJM1990101832316022215576Open DOISearch in Google Scholar

20. Thomas W, Dooley R, Harvey BJ. Aldosterone as a renal growth factor. Steroids. 2010 Aug 1;75(8-9):550-4. DOI:510.1016/j10.1016/j.steroids.2009.09.00819782095Search in Google Scholar

21. Amico P, Kalbermatter S, Kiss D. Aliskiren corrects recurrent hyperreninemia and hyperaldosteronism in autosomal dominant polycystic kidney disease. Clinical nephrology. 2009 Sep;72(3):237-9.10.5414/CNP7223719761733Open DOISearch in Google Scholar

22. Hirai H, Kanno M, Watanabe T, Satoh H. Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report. Experimental and therapeutic medicine. 2017 Aug 1;14(2):1235-40. http://doi.org/10.3892/etm.2017.458810.3892/etm.2017.4588552564728810583Open DOISearch in Google Scholar

23. Vutthikraivit W., Assanatham M.,& Sriphrapradang C.(2016) Hypokalemic Hypertension Leading to a Diagnosis of Autosomal Dominant Polycystic Kidney Disease. Electrolytes & Blood Pressure: E & BP; 14(1):11-15. DOI 10.5049/EBP.2016.14.1.1110.5049/EBP.2016.14.1.11494920227453714Open DOISearch in Google Scholar

24. Lumachi F, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Favia G, Bui F. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nuclear medicine communications. 2003 Jun 1;24(6):683-8. DOI: 10.1097/01. mnm.0000075198.18521.2510.1097/01Search in Google Scholar

25. Lingam RK, Sohaib SA, Vlahos I, Rockall AG, Isidori AM, Monson JP, Grossman A, Reznek RH. CT of primary hyperaldosteronism (Conn’s syndrome): the value of measuring the adrenal gland. American Journal of Roentgenology. 2003 Sep;181(3):843-9. DOI: 10.2214/ajr.181.3.181084310.2214/ajr.181.3.181084312933492Open DOISearch in Google Scholar